tradingkey.logo

Inmode Ltd

INMD
查看详细走势图
13.400USD
-0.350-2.55%
收盘 03/27, 16:00美东报价延迟15分钟
856.17M总市值
9.23市盈率 TTM

Inmode Ltd

13.400
-0.350-2.55%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-2.55%

5天

-0.96%

1月

-2.55%

6月

-10.07%

今年开始到现在

-8.78%

1年

-24.29%

查看详细走势图

TradingKey Inmode Ltd股票评分

单位: USD 更新时间: 2026-03-27

操作建议

Inmode Ltd当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名68/208位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价16.80。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Inmode Ltd评分

相关信息

行业排名
68 / 208
全市场排名
176 / 4542
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Inmode Ltd亮点

亮点风险
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
估值合理
公司最新PE估值9.23,处于3年历史合理位
机构减仓
最新机构持股37.36M股,环比减少28.82%
Hotchkis & Wiley持仓
明星投资者Hotchkis & Wiley持仓,最新持仓市值864.14K

分析师目标

根据 7 位分析师
持有
评级
17.000
目标均价
+23.64%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Inmode Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Inmode Ltd简介

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
公司代码INMD
公司Inmode Ltd
CEOMizrahy (Moshe)
网址https://inmodemd.com/
KeyAI